---

Image

---

X (formerly Twitter):  #Conversations on Cancer 

Sponsored by the U.S. Food & Drug Administration (FDA)

Registration required to attend: https://www.surveymonkey.com/r/GX7KLGB

Background:

FDA Oncology Center of Excellence (OCE) presents a Conversations on Cancer public panel discussion November 30, 2023, examining the challenge of developing new treatments for cancer, and what it takes to bring a new drug from research and development to patients with cancer. In this special edition of Conversation on Cancer, OCE interviews author and journalist Nathan Vardi.  Mr. Vardi is a managing editor at MarketWatch and former senior editor at Forbes. He writes about big money investors, hedge funds, private equity firms, and the intersection of Wall Street and biopharma. He is the author of the book “For Blood and Money.”  

The purpose of this discussion is educational.  The views and opinions expressed during this discussion do not represent those of the U.S. Food and Drug Administration. This is not an endorsement of the author or his publications.  

Panelists:
Rea Blakey, Associate Director, External Outreach and Engagement, Oncology Center of Excellence (OCE), FDA
Jennifer Gao, MD, Associate Director for Education, OCE, FDA
Richard Pazdur, MD, Director, OCE, FDA
Nathan Vardi, Author| Journalist 

Webcast Information:
A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above. 
FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer

Contact:
For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov